Publikationsdatenbank

Die Publikationsdatenbank enthält alle Artikel von HZI-Mitarbeitenden (ehemals Gesellschaft für Biotechnologische Forschung (GBF)) seit 2000.

Hueging,K., Weller,R., Doepke,M., Vieyres,G., Todt,D., Wolk,B., Vondran,F.W., Geffers,R., Lauber,C., Kaderali,L., ... , Penin,F., Pietschmann,T. (2015)
Several Human Liver Cell Expressed Apolipoproteins Complement HCV Virus Production with Varying Efficacy Conferring Differential Specific Infectivity to Released Viruses
PLoS ONE 10 (7)
Perin,P.M., Haid,S., Brown,R.J., Doerrbecker,J., Schulze,K., Zeilinger,C., von,Schaewen M., Heller,B., Vercauteren,K., Luxenburger,E., Baktash,Y.M., Vondran,F.W., Speerstra,S., Awadh,A., Mukhtarov,F., Schang,L.M., Kirschning,A., Müller,R., Guzmán,C.A., Kaderali,L., Randall,G., Meuleman,P., ... , Ploss,A., Pietschmann,T. (2016)
Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1
Hepatology 63
Wang,H., El Maadidi,S., Fischer,J., Grabski,E., Dickhöfer,S., Klimosch,S., Flannery,S.M., Filomena,A., Wolz,O.O., Schneiderhan-Marra,N., Löffler,M.W., Wiese,M., Pichulik,T., Mullhaupt,B., Semela,D., Dufour,J.F., Bochud,P.Y., East-German and Swiss Hepatitis C Virus Study Groups, Bowie,A.G., Kalinke,U., ... , Berg,T., Weber,A.N. (2015)
A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance
Hepatology 62
Bruchmann,S., Muthukumarasamy,U., Pohl,S., Preusse,M., Bielecka,A., Nicolai,T., Hamann,I., Hillert,R., Kola,A., Gastmeier,P., ... , Eckweiler,D., Häußler,S. (2015)
Deep transcriptome profiling of clinical Klebsiella pneumoniae isolates reveals strain- and sequence type-specific adaptation
Environ.Microbiol. 17
Stöhr,S., Costa,R., Sandmann,L., Westhaus,S., Pfaender,S., Anggakusuma, Dazert,E., Meuleman,P., Vondran,F.W., Manns,M.P., Steinmann,E., ... , von Hahn,T., Ciesek,S. (2015)
Host cell mTORC1 is required for HCV RNA replication
GUT 65
Lump,E., Castellano,L.M., Meier,C., Seeliger,J., Erwin,N., Sperlich,B., Sturzel,C.M., Usmani,S., Hammond,R.M., von,Einem J., Gerold,G., Kreppel,F., Bravo-Rodriguez,K., Pietschmann,T., Holmes,V.M., Palesch,D., Zirafi,O., Weissman,D., Sowislok,A., Wettig,B., Heid,C., Kirchhoff,F., Weil,T., Klarner,F.G., Schrader,T., Bitan,G., Sanchez-Garcia,E., Winter,R., ... , Shorter,J., Munch,J. (2015)
A molecular tweezer antagonizes seminal amyloids and HIV infection
Elife. 4
Schweitzer,A., Krause,G., Pessler,F., Akmatov,M.K. (2015)
Improved coverage and timing of childhood vaccinations in two post-Soviet countries, Armenia and Kyrgyzstan
BMC Public Health 15 (1)
Smith,K.A., Filbey,K.J., Reynolds,L.A., Hewitson,J.P., Harcus,Y., Boon,L., Sparwasser,T., ... , Hammerling,G., Maizels,R.M. (2016)
Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths
Mucosal.Immunol. 9 (2)
Lepeltier,E., Loretz,B., Desmaele,D., Zapp,J., Herrmann,J., ... , Couvreur,P., Lehr,C.M. (2015)
Squalenoylation of Chitosan: A Platform for Drug Delivery?
Biomacromolecules. 16 (9)
Schneider,M., Loretz,B., Windbergs,M., Schneider-Daum,N., Schaefer,U.F., Lehr,C.M. (2015)
Biological barriers - Advanced drug delivery, in vitro modelling, and their implications for infection research
Eur.J Pharm.Biopharm 95